Skip to main content
TipRanks
Go Ultimate75% OFF

bioAffinity Technologies, Inc. (BIAF) Financial Statements

251 Followers

bioAffinity Technologies, Inc. Financial Overview

bioAffinity Technologies, Inc.'s market cap is currently $4.00M. The company's EPS TTM is $-54.94; its P/E ratio is -0.04; bioAffinity Technologies, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 6.16M$ 9.36M$ 2.53M$ 4.80K$ 0.00
Gross Profit$ 1.43M$ 3.38M$ 791.62K$ 4.34K$ -4.82K
Operating Income$ -10.57M$ -8.95M$ -7.97M$ -4.01M$ -2.21M
EBITDA$ -14.32M$ -8.33M$ -7.63M$ -5.61M$ -5.32M
Net Income$ -14.91M$ -9.04M$ -7.94M$ -8.15M$ -6.33M
Balance Sheet
Cash & Short-Term Investments$ 6.45M$ 1.11M$ 2.82M$ 11.41M$ 1.36M
Total Assets$ 10.96M$ 6.51M$ 8.22M$ 12.18M$ 1.45M
Total Debt$ 1.16M$ 1.50M$ 1.58M$ 251.75K$ 11.36M
Net Debt$ -5.29M$ 395.90K$ -1.24M$ -11.16M$ 10.00M
Total Liabilities$ 3.68M$ 3.91M$ 3.37M$ 1.14M$ 17.24M
Stockholders' Equity$ 7.28M$ 2.60M$ 4.86M$ 11.04M$ -15.79M
Cash Flow
Free Cash Flow$ -9.39M$ -7.34M$ -6.06M$ -4.29M$ -2.05M
Operating Cash Flow$ -9.33M$ -7.26M$ -6.04M$ -4.07M$ -2.05M
Investing Cash Flow$ -60.57K$ -79.08K$ -2.21M$ -219.99K$ 0.00
Financing Cash Flow$ 14.73M$ 5.63M$ -344.98K$ 14.34M$ 3.33M

Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

-24M-12M012M-180000 %-120000 %-60000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

bioAffinity Technologies, Inc. Liabilities to Assets

08M16M24M0 %4000 %8000 %12000 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

bioAffinity Technologies, Inc. Cash Flow

-15M-10M-5M05M10M15M20M2019202020212022202320242025OperatingInvestingFinancing

bioAffinity Technologies, Inc. Forecast EPS vs Actual EPS

-100-50050100150Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss